Abstract
In this thesis we have studied the pharmacokinetics, safety and analgesic properties of intrathecal administration of methylprednisolone acetate (MPA) suspension in neuropathic pain states, both in patients and preclinical models. In conclusion, intrathecal MPA does not decrease pain or pain-like behavior in severe neuropathic pain states in patients or rats, respectively, and is a potentially harmful treatment that should not be offered to patients.
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 26 May 2016 |
| Publisher | |
| Print ISBNs | 978-90-9029700-2 |
| Publication status | Published - 26 May 2016 |
Fingerprint
Dive into the research topics of 'Intrathecal glucocorticoids for neuropathic pain'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver